Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-17-066820

Chief Financial Officer gave up 775 shares (to pay taxes)

  • Chief Financial Officer acquired 2,550 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ruffo Frank Chief Financial Officer 2017-12-15 Option exercise +1,300 144,872 D: show line 1 in the form
Ruffo Frank Chief Financial Officer 2017-12-15 Shares withheld for taxes −395 $24.23 $9,571 144,477 D: show line 2 in the form
Ruffo Frank Chief Financial Officer 2017-12-18 Option exercise +1,250 145,727 D: show line 3 in the form
Ruffo Frank Chief Financial Officer 2017-12-18 Shares withheld for taxes −380 $24.12 $9,166 145,347 D: show line 4 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Ruffo Frank Chief Financial Officer 2017-12-15 Option exercise · Restricted Stock Units −1,300 9,100 D: show line 5 in the form
Ruffo Frank Chief Financial Officer 2017-12-18 Option exercise · Restricted Stock Units −1,250 2,500 D: show line 6 in the form
Loading xslF345X03/doc4.xml…